Type A Botulinum Toxins FDA Link

A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.

Also Known As:

Botox; Botulinum A Toxin; Botulinum Toxins, Type A; Botulinum Neurotoxin A; Clostridium Botulinum Toxin Type A; Clostridium botulinum A Toxin; Meditoxin; Neuronox; Oculinum; Onabotulinumtoxin A; OnabotulinumtoxinA; Vistabel; Vistabex; Neurotoxin A, Botulinum; Toxin A, Botulinum; Toxin, Botulinum A; Botulinum Neurotoxin Type A; Botulinum Toxin A; Botulinum Toxin Type A

Pharmalogical Action Categories:

Acetylcholine Release Inhibitors
Neuromuscular Agents
Neurotoxins

Enzymes and Coenzymes: 1
- Enzymes: 155591
  - Hydrolases: 2206
    - Peptide Hydrolases: 24289
      - Metalloproteases: 8398
        Metalloendopeptidases: 70
        Botulinum Toxins: 7103
        Type A Botulinum Toxins: 6197
      - Endopeptidases: 643
        Metalloendopeptidases: 70
        Botulinum Toxins: 7103
        Type A Botulinum Toxins: 6197
Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Bacterial Proteins: 401
    - Botulinum Toxins: 7103
      - Type A Botulinum Toxins: 6197
Biological Factors: 2560
- Biological Toxins: 20
  - Bacterial Toxins: 828
    - Botulinum Toxins: 7103
      - Type A Botulinum Toxins: 6197

GENULF and the AFU Committee of NeuroUrology Selected Research

GENULF and the AFU Committee of NeuroUrology Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure